Parametric Portfolio Associates LLC lifted its stake in shares of CVS Health Corp (NYSE:CVS) by 71.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,949,854 shares of the pharmacy operator’s stock after buying an additional 1,647,168 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.39% of CVS Health worth $317,805,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in CVS. Vanguard Group Inc. boosted its holdings in shares of CVS Health by 1.4% during the second quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock valued at $6,159,825,000 after acquiring an additional 1,056,265 shares during the period. FMR LLC boosted its holdings in shares of CVS Health by 22.0% during the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after acquiring an additional 5,446,930 shares during the period. Bank of America Corp DE boosted its holdings in shares of CVS Health by 1.8% during the first quarter. Bank of America Corp DE now owns 22,411,957 shares of the pharmacy operator’s stock valued at $1,759,338,000 after acquiring an additional 398,999 shares during the period. Northern Trust Corp boosted its holdings in shares of CVS Health by 5.5% during the second quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock valued at $1,256,631,000 after acquiring an additional 807,639 shares during the period. Finally, Nordea Investment Management AB boosted its holdings in shares of CVS Health by 8.4% during the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock valued at $1,138,905,000 after acquiring an additional 1,100,373 shares during the period. 82.24% of the stock is owned by institutional investors and hedge funds.
Shares of CVS Health Corp (NYSE:CVS) traded up $0.37 during trading on Thursday, reaching $71.38. 12,371,700 shares of the company’s stock traded hands, compared to its average volume of 6,904,070. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.72. The company has a market capitalization of $71,932.56, a PE ratio of 12.44, a PEG ratio of 1.22 and a beta of 0.89.
Several equities analysts have recently issued reports on CVS shares. Needham & Company LLC reissued a “hold” rating on shares of CVS Health in a report on Sunday, September 10th. Oppenheimer reissued a “buy” rating and set a $95.00 price target on shares of CVS Health in a report on Monday, October 9th. Leerink Swann reissued an “outperform” rating and set a $85.00 price target (down previously from $90.00) on shares of CVS Health in a report on Tuesday, November 7th. BidaskClub cut shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Finally, SunTrust Banks set a $85.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research note on Thursday, October 12th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $86.35.
In other CVS Health news, CFO David M. Denton sold 237,078 shares of the business’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the sale, the chief financial officer now directly owns 141,096 shares in the company, valued at $11,238,296.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the sale, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The disclosure for this sale can be found here. Over the last quarter, insiders sold 714,125 shares of company stock worth $58,119,381. 0.61% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “CVS Health Corp (CVS) Stake Increased by Parametric Portfolio Associates LLC” was published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3079689/cvs-health-corp-cvs-stake-increased-by-parametric-portfolio-associates-llc.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.